Parente Luca
Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy.
BMC Pharmacol Toxicol. 2017 Jan 5;18(1):1. doi: 10.1186/s40360-016-0111-8.
Deflazacort is a synthetic corticosteroid characterized by a favourable pharmacokinetic profile, peculiar pharmacodynamic properties and a good safety profile. However, to the best of our knowledge, no dose-conversion table based on direct comparison of relative potencies between deflazacort and other main corticosteroids is currently available in scientific literature.
This paper, while reporting a brief review of deflazacort pharmacological properties, its efficacy and tolerability in different clinical areas, has been designed with the specific aim of providing a new dose-conversion table of corticosteroids, including for the first time also deflazacort.
We suggest that this new conversion table could be a useful tool for physicians who need to select the appropriate dose of deflazacort in their clinical practice.
地夫可特是一种合成皮质类固醇,具有良好的药代动力学特征、独特的药效学特性和良好的安全性。然而,据我们所知,目前科学文献中尚无基于地夫可特与其他主要皮质类固醇相对效价直接比较的剂量换算表。
本文在简要回顾地夫可特的药理特性、其在不同临床领域的疗效和耐受性的同时,旨在提供一种新的皮质类固醇剂量换算表,首次纳入了地夫可特。
我们认为,这一新的换算表对于需要在临床实践中选择合适剂量地夫可特的医生而言可能是一个有用的工具。